"Expertise in optimizing
non-clinical safety assessments required for successful product development."

Credentials

  • D.V.M., Ph.D
  • Diplomate, American College of Veterinary Pathologists
  • Fellow, The Academy of Toxicological Sciences
  • Fellow, International Academy of Toxicologic Pathology

Toxicology Experience

  • 15 years at CIIT
  • Over 10 years in the pharmaceutical industry
  • Over 9 years as consultant
  • Over 135 publications

Expertise

  • Nonclincial safety assessment related to drug development
  • Problem resolution in toxicology
  • Hepatotoxicity
  • Carcinogenicity
  • Management of toxicology groups

Offices Held

  • Past President, Society of Toxicology
  • Past President, The Academy of Toxicological Sciences
  • Past President, Society of Toxicologic Pathology
  • Past Councilor, American College of Veterinary Pathology

Consulting and Advisory Experience

  • Pharmaceutical and chemical companies on specific issues
  • Pharmaceutical company program reviews
  • Preparation for regulatory agency interactions at all stages of drug development
  • Consumer product company advisory panels
  • Government review and advisory panels
  • International agency review and advisory panels

Recent Publications

  • Editor Books
    • Sahota, P.S., Popp, J. A., Hardisty, J.A., Gopinath, C. eds: Toxicologic Pathology: Nonclincial Safety Assessment. CRC Press, Taylor and Francis Group, New York, New York. 2013
  • Author Book Chapters
    • Popp, J.A., Englehardt, J.A.: Overview of Drug Development. In: Toxicologic Pathology: Nonclincial Safety Assessment. Sahota, P.S., Popp, J. A., Hardisty, J.A., Gopinath, C. eds. CRC Press, Taylor and Francis Group. Pp.3-24 (2013)
    • Cattley, R.C., Popp, J.A., Vonderfecht S.L.: Liver, Gall Bladder and Exocrine Pancreas. In: Toxicologic Pathology: Nonclincial Safety Assessment. Sahota, P.S., Popp, J. A., Hardisty, J.A., Gopinath, C. eds. CRC Press, Taylor and Francis Group. Pp. 313-366 (2013)
    • Popp J.A., Bogdanffy, M. S.: Evaluation of Potential Carcinogenicity. In: Nonclinical Safety Assessment: A Guide to International Pharmaceutical Regulations. Brock W., Hastings K., McGowan K.M. Eds. John Wiley and Sons, Inc. pp. 219-254 (2013)
  • Review article/Position paper
    • Corton J.C., Cunningham M.L., Hummer B.T., Lau C., Meek B., Peters J.M., Popp J.A., Seed J., Klaunig J.E.: Mode of Action Framework Analysis for Receptor-mediated Toxicity: The Peroxisome Proliferator-activated Receptor-alpha (PPARa) as a Case Study. Crit Rev Toxicol 44(1):1-49 (2014)

Curriculum Vitae available upon request

 

Stratoxon LLC
1853 William Penn Way, Lancaster, PA 17601
Phone:717-735-3646 • 717-735-3647 Fax: 717-293-4470

popp@stratoxon.com

Stratoxon LLC. All rights reserved.